Key Moments
The Effects of Cannabis (Marijuana) on the Brain & Body
Andrew HubermanKey Moments
Cannabis effects: biology, medical uses, risks (psychosis, brain development, hormones), and individual variability.
Key Insights
Cannabis (THC, CBD) binds to endogenous cannabinoid receptors (CB1, CB2) with much greater potency than natural cannabinoids, effectively outcompeting them and causing a range of strong effects.
Different cannabis strains (sativa, indica, hybrids) and their THC:CBD ratios produce varied effects, from stimulant-like (sativa) to sedative (indica), affecting mood, focus, memory, and appetite.
Cannabis impacts creativity indirectly by increasing openness to new experiences and reducing anxiety in some individuals, rather than directly boosting creative capacity.
Chronic cannabis use (twice a week or more) is linked to increased anxiety and depression over time, potentially leading to a dependence where the drug is used to alleviate these very symptoms.
Cannabis use (smoking, vaping, edibles) during pregnancy and lactation is a severe concern due to the critical role of cannabinoid receptors in fetal brain development, with currently unknown but potentially detrimental long-term consequences.
Adolescent and young adult cannabis use (ages 14-25) significantly accelerates prefrontal cortex thinning, increasing the risk of psychosis (schizophrenia, bipolar-like episodes), especially with higher THC potency and pre-existing genetic predispositions.
CHEMICAL DIVERSITY AND STRAIN VARIETIES OF CANNABIS
Cannabis, commonly known as marijuana, is a complex plant containing numerous compounds with profound impacts on the brain and body. While THC (Delta-9-tetrahydrocannabinol) is the most recognized psychoactive compound, CBD (cannabidiol) and CBN (cannabinol) also play significant roles. Beyond these, cannabis boasts over 70 psychoactive and 400 biologically active compounds, warranting substantial future research. Different strains like Sativa and Indica, along with Ruderalis (less commonly consumed) and various hybrids, present distinct morphological features and unique effects. The emerging classification of Type 1, Type 2, and Type 3 strains further categorizes cannabis based on the critical THC to CBD ratio, with Type 1 being THC-dominant, Type 2 having equal ratios, and Type 3 being CBD-dominant, profoundly influencing their impact.
THE ENDOGENOUS CANNABINOID SYSTEM AND EXOGENOUS INTERACTION
The human body possesses a natural endocannabinoid system, integral from conception, comprising cannabinoid receptors (CB1 and CB2) and endogenous cannabinoids like anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These endogenous compounds are naturally released by neurons and regulate various biological processes, including mood, appetite, perception, and immune function. THC and CBD from cannabis bind to these same CB1 and CB2 receptors, but with significantly greater potency and affinity. This exogenous binding effectively outcompetes the natural endocannabinoids, altering their nuanced regulatory effects. CB1 receptors are predominantly found in the nervous system, including the brain, while CB2 receptors are mainly located in bodily tissues such as the immune system and liver.
RAPID ONSET AND PROLONGED PRESENCE IN THE BODY
When cannabis is consumed, its psychoactive compounds rapidly enter the bloodstream, reaching the brain and body tissues within 30 seconds. Peak concentrations and biological effects typically occur between 30 to 60 minutes, lasting approximately 3 to 4 hours, though individual metabolism and prior use can cause variations. THC and CBD are highly lipophilic, meaning they readily penetrate and remain in fatty tissues, including cell membranes and body fat. Consequently, these compounds can be detected in the system for at least 80 days post-ingestion, a crucial factor for drug testing and highlighting their prolonged presence and potential for sustained biological effects.
VARIED EFFECTS OF CANNABIS STRAINS ON BRAIN AND BEHAVIOR
Cannabis sativa varieties typically induce stimulant-like effects, promoting elevated mood, alertness, talkativeness, and a heightened sense of focus or creativity, often described as a 'head high.' This is attributed to CB1 activation in the prefrontal cortex, which modulates limbic circuitry responsible for stress. Conversely, Indica varieties generally lead to full-body relaxation, sedation, and a 'couch-lock' sensation, making them popular for sleep promotion and anxiety relief. While the identical compounds (THC/CBD) bind to the same CB1 receptors, their location-dependent effects determine whether they increase activity in some brain areas (e.g., prefrontal cortex for focus) or suppress activity in others (e.g., amygdala for stress, hippocampus for memory). This dual action explains the diverse and sometimes opposing effects observed across different strains.
IMPACT ON MEMORY, MOTOR CONTROL, AND APPETITE
Regardless of strain or consumption method, cannabis consistently impacts certain brain functions. Memory deficits, particularly short-term memory impairment, are nearly universally observed due to reduced electrical activity in the hippocampus. Motor control is also disrupted; both sativa and indica strains suppress activity in the basal ganglia and cerebellum, brain regions vital for action planning, initiation, and balance. This explains why users often exhibit reduced physical mobility. Additionally, cannabis use commonly leads to 'the munchies'— an increase in appetite— due to high concentrations of CB1 receptors in the hypothalamus. These receptors activate neurons that strongly stimulate appetite, both through cognitive preoccupation with food and direct signaling to the gut, influencing blood sugar regulation.
CREATIVITY: A MATTER OF 'OPENNESS TO EXPERIENCE'
The relationship between cannabis and creativity is nuanced. While many users report enhanced creativity, scientific studies reveal that cannabis doesn't directly boost neural circuits for creativity. Instead, it appears to foster creativity by increasing an individual's 'openness to experience' and reducing anxiety, factors crucial for divergent thinking (brainstorming). Dopamine, a key neuromodulator, plays a central role; high but not excessively high dopamine levels facilitate divergent thinking, allowing individuals to explore a wide range of ideas. As dopamine levels decrease, convergent thinking—the process of synthesizing and refining ideas—becomes more likely. Cannabis users, whether or not they are currently under its influence, tend to exhibit higher openness, leading to a willingness to consider more disparate ideas, which indirectly supports the creative process. However, for those who experience anxiety from cannabis, this openness may not manifest.
ALTERED SPEECH PATTERNS IN CHRONIC USERS
Chronic cannabis use, defined as twice a week or more, leads to noticeable changes in speech patterns, even when individuals are not under the influence. This is partly due to the impact of cannabis on the basal ganglia and cerebellum, brain areas critical for motor control, which also govern speech articulation. Studies show that chronic users exhibit reduced 'spectral tilt'—meaning decreased vocal effort and intensity—resulting in a flatter, less accented speaking style. There are also alterations in verbal timing, with less emphasis on specific words or syllables. While not every user exhibits extreme changes, these subtle shifts in enunciation, inflection, and even laughter patterns are consistently observed, impacting the fluidity and expressiveness of communication.
CANNABIS, LIBIDO, AND HORMONAL IMPACTS
Cannabis's influence on sexual desire and function is highly individual. Some individuals report increased libido and arousal under cannabis intoxication, while others experience suppression. Research indicates that this divergence is modulated by individual prolactin responses to cannabis. For those whose prolactin levels *do not* rise with cannabis use, sexual arousal pathways (like the nucleus accumbens, rich in dopamine) are activated, leading to increased desire. Conversely, individuals experiencing elevated prolactin levels, which are mutually inhibitory with dopamine, show no such activation and report diminished arousal. Beyond acute effects, chronic cannabis use (more than twice weekly) is clearly linked to increased prolactin levels in both men and women. This, in turn, can reduce dopamine and testosterone, and elevate aromatase enzymes, which convert testosterone into estrogen, potentially contributing to conditions like gynecomastia in men and impacting sperm motility and fertility in both sexes.
SMOKING, VAPING, AND ENDOTHELIAL CELL DAMAGE
Regardless of the substance, both smoking and vaping (tobacco or cannabis) inflict severe damage on the body's endothelial cells—the lining of capillaries and blood vessels. This damage is independent of the psychoactive substances being delivered. Impaired endothelial function reduces cognitive capacity over time, increases the risk of strokes, severely impacts lung function, causes peripheral neuropathies, and leads to sexual dysfunction due to compromised blood flow to the genitals. While vaping was initially thought to be safer than smoking, it also presents a significant number of distinct negative health effects. This makes any method of inhaled cannabis consumption inherently detrimental to cardiovascular and overall health.
AGE: THE SINGLE MOST CRITICAL FACTOR FOR CANNABIS HAZARDS
The age at which cannabis is consumed is the most crucial determinant of its potential harm. Cannabinoid receptors (CB1 and CB2) are extensively involved in fetal and adolescent brain development, with endogenous cannabinoids naturally present at higher levels during these periods. The introduction of exogenous THC and CBD during these critical developmental stages, particularly during pregnancy and adolescence, can severely disrupt normal brain wiring. Shockingly, 15% of pregnant mothers in the US self-report cannabis use, despite strong medical contraindications. The lipophilic nature of cannabis compounds allows them to readily cross the placental barrier and enter breast milk, posing unknown but potentially severe risks to developing fetuses and newborns.
ADOLESCENT CANNABIS USE: ACCELERATED BRAIN THINNING AND PSYCHOSIS RISK
Cannabis use between the ages of 14 and 25 (the period of ongoing brain development) significantly accelerates the thinning of the prefrontal cortex gray matter. This brain region is vital for executive functions, emotional regulation, planning, and impulse control—all fundamental for developing a functional human being. Higher frequency and potency of cannabis use are directly correlated with more extensive and rapid cortical thinning, leading to impaired cognitive processes. Even small amounts of use in this age bracket are concerning. Furthermore, chronic cannabis use (more than twice a week), especially with high THC potency, is associated with a four-fold increased risk of psychosis, including schizophrenia and bipolar-like episodes, particularly for individuals with a genetic predisposition. This risk is amplified for those who initiate cannabis use at even younger ages (12-14), underscoring a serious public health concern, especially given the rising use among young adults and the increase in high-potency products.
ANXIETY, DEPRESSION, AND THE POTENCY PARADOX
Chronic cannabis use, even with strains initially intended for anxiety relief, progressively increases anxiety levels over time. The initial anxiolytic effects diminish, requiring higher doses or more frequent use to achieve the same or even reduced benefits. This is due to homeostatic adjustments in the G protein-coupled CB1 receptors and their downstream signaling, leading to fewer available receptors or less robust signaling. Moreover, cannabis use itself increases the likelihood of developing major depression fourfold, even in individuals who were not depressed prior to use. This creates a dependency loop where cannabis is used to cope with anxiety and depression that it itself induces or exacerbates. The increased potency of modern cannabis strains further compounds these risks, as higher THC concentrations are directly linked to a greater probability of developing psychosis, major depression, and severe anxiety disorders.
UNDERSTANDING THE BALANCED PERSPECTIVE
While the negative health consequences of cannabis, particularly for young, developing brains, are stark and undeniable, it's crucial to acknowledge its documented medical benefits for adults. Cannabis has shown efficacy in reducing pain (especially in chemotherapy), alleviating nausea in cancer patients, and lowering intraocular pressure in glaucoma. These therapeutic applications are typically observed with carefully selected strains, controlled dosages (often edible), and in adults. The discussion around cannabis must extend beyond legalization or recreational appeal to a nuanced understanding of its complex biological mechanisms, individual variability in response, and particularly acute risks to vulnerable populations like pregnant mothers and adolescents. Informed choice requires a complete picture of both potential benefits and serious hazards, especially as product potency increases and societal perceptions shift.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Companies
●Organizations
●Books
●Drugs & Medications
●Concepts
●People Referenced
Common Questions
Cannabis includes Sativa, Indica, and hybrid strains. Sativa usually acts as a stimulant, increasing alertness and focus ('head high'), while Indica tends to be more sedative, promoting relaxation and sleep ('in da couch'). Hybrid strains combine these effects. Additionally, strains are categorized into Type 1 (THC dominant), Type 2 (equal THC/CBD), and Type 3 (high CBD).
Topics
Mentioned in this video
Host of the Huberman Lab podcast, professor of neurobiology and ophthalmology at Stanford School of Medicine.
Professor at Rockefeller University and neuroscientist specializing in language and speech control, who notes the link between speech and movement.
A doctor previously on the podcast who verified information about edible marijuana's prolactin effects.
First author of 'Adults with history of recreational cannabis use have altered speech production'.
Chair of Neurosurgery at UCSF, expert in language and speech neuroscience, who can often predict cannabis use from speech patterns and neural recordings.
A neuromodulator involved in motivation, attention, and creativity; its levels strongly correlate with convergent and divergent thinking.
A brain region associated with memory, where cannabis typically causes reductions in electrical activity, leading to short-term memory deficits.
Brain areas involved in action planning and withholding action (go/no-go circuitry), impacted by cannabis, leading to reduced physical mobility.
A hormone released from the hypothalamus that is strongly inhibited by THC, impacting LH, FSH, and reproductive function.
A receptor highly enriched in the nervous system, especially the brain, responsible for most familiar effects of cannabis.
A variety of cannabis less commonly consumed for medicinal or recreational purposes.
A receptor largely located on bodily tissues, including the immune system, liver, and genitals.
A variety of cannabis known to be shorter and stouter, and typically associated with sedative effects, full-body relaxation, and anxiety relief ('in da couch').
Enzymes that convert testosterone into estrogen, reportedly elevated with chronic marijuana use, possibly linked to gynecomastia.
A brain region largely responsible for executive functions like planning, decision-making, and emotional regulation.
A brain region involved in balance, motor planning, and motor sequencing, impacted by cannabis leading to less physical mobility.
A stress hormone that tends to negatively correlate with sexual arousal; cannabis has divergent effects on its levels.
A hormone released from the pituitary, reduced by cannabis use, supporting normal ovarian and testicular function.
A deep relaxation practice similar to NSDR but traditionally includes intentions and mystical components.
A variety of cannabis known to be taller, with longer leaves, and typically associated with stimulating effects like alertness, focus, creativity, and pain relief ('head high').
A naturally occurring chemical in the body that binds to nicotinic receptors, creating an enhanced sense of focus.
A brain region involved in threat detection and emotional processing; cannabis can suppress its activation, reducing stress.
A hormone that can increase in response to cannabis use, mutually inhibitory with dopamine, affecting sexual arousal and testosterone.
A behavioral practice for deep relaxation, sleep recovery, and restoring dopamine levels, with neurochemical and psychological benefits.
A brain region with high CB1 receptor density, where cannabis activation stimulates appetite, leading to 'munchies'.
A hormone released from the pituitary, reduced by cannabis use, supporting normal ovarian and testicular function.
The journal where Emily Lafrance's paper 'Inspired by Mary Jane: mechanisms underlying enhanced creativity in cannabis users' was published.
The journal that published a 2017 paper on individual prolactin reactivity and cannabis influence on sexual arousal.
A premier medical journal that published a 2022 paper 'Association of cannabis potency with mental ill health and addiction: a systematic review'.
The journal where Adam Vogel's study on cannabis and speech production was published.
A university in Canada noted for producing strong data on the negative effects of marijuana related to the criminal justice system.
The institution where Andrew Huberman is a professor.
Cited as the source for statistics on global illicit drug use.
A foundation that provides a dollar-for-dollar match for funds raised for research through the Huberman Lab Premium Channel.
A lesser-discussed psychoactive compound in cannabis, relevant to the discussion.
A supplement company partnered with Huberman Lab, known for high-quality single-ingredient formulations and international shipping.
A compound in cannabis known for pain and anxiety management, generally not psychoactive.
One of the two main endogenous cannabinoids, naturally released from neurons to regulate communication.
The primary psychoactive compound in cannabis, largely responsible for altered mood and perception.
One of the two main endogenous cannabinoids, naturally released from neurons to regulate communication.
High doses can lead to increased estrogen and breast tissue development, similar to some cannabis effects.
A platform where a free 10-minute NSDR script read by Andrew Huberman can be found.
A program offering real-time feedback on diet using a continuous glucose monitor to help manage blood sugar.
A personalized nutrition platform that analyzes blood and DNA data to provide actionable health recommendations.
A company that hosts Huberman's NSDR protocol on their YouTube channel and has an app with health and wellness protocols.
More from Andrew Huberman
View all 342 summaries
40 minBenefits of Sauna & Deliberate Heat Exposure | Huberman Lab Essentials
148 minAvoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
31 minEssentials: The Biology of Taste Perception & Sugar Craving | Dr. Charles Zuker
189 minUnlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free